Logo image of OPK

OPKO HEALTH INC (OPK) Stock News

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.36  +0.03 (+2.26%)

OPK Latest News, Press Relases and Analysis

News Image
7 days ago - OPKO Health, Inc.

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including...

News Image
2 months ago - Zacks Investment Research

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands

Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.

Mentions: BSX ITGR EHC

News Image
2 months ago - Zacks Investment Research

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for OPKO Health (OPK) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

News Image
2 months ago - Zacks Investment Research

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -66.67% and 8.87%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: TCMD

News Image
2 months ago - OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time today...

News Image
2 months ago - Zacks Investment Research

Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround

OPKO Health (OPK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

News Image
2 months ago - Stocktwits

This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge?

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.

Mentions: NXPL IWC BABA

News Image
2 months ago - NextPlat Corp.

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

/PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today provided an update on the impact of...

Mentions: NXPL

News Image
2 months ago - OPKO Health, Inc.

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100...

News Image
3 months ago - Yahoo Finance

Is FactSet Research Systems (FDS) The Most Expensive Stock Insiders Are Dumping In March?

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where FactSet Research Systems Inc. (NYSE:FDS) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader […]

Mentions: FDS COMP MDGL GIS ...

News Image
3 months ago - Labcorp Holdings Inc

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...

Mentions: LH

News Image
4 months ago - The Motley Fool

Opko Health (OPK) Q4 2024 Earnings Call Transcript

OPK earnings call for the period ending December 31, 2024.

News Image
4 months ago - OPKO Health, Inc.

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time today...

News Image
4 months ago - OPKO Health, Inc.

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months...

News Image
5 months ago - OPKO Health, Inc.

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P....

News Image
6 months ago - MarketBeat

3 Stocks That Wall Street Insiders Can’t Stop Buying

Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.

Mentions: GEF VSTS CTAS UNF

News Image
6 months ago - NextPlat Corp.

NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer

/PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced a significant expansion of its...

Mentions: NXPL

News Image
7 months ago - NextPlat Corp.

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

/PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider, today announced that it is participating in...

Mentions: NXPL

News Image
7 months ago - The Motley Fool

Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.

News Image
8 months ago - OPKO Health, Inc.

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months...

News Image
8 months ago - OPKO Health, Inc.

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205...

News Image
9 months ago - Labcorp Holdings Inc

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...

Mentions: LH

News Image
10 months ago - OPKO Health, Inc.

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time today...